Macrobid Dosing and Frequency
For adults with uncomplicated UTI, prescribe Macrobid (nitrofurantoin monohydrate/macrocrystals) 100 mg twice daily for 5 days, taken with food. 1, 2
Adult Dosing for Uncomplicated Cystitis
The most current European guidelines recommend nitrofurantoin as first-line therapy for acute cystitis in women 1. The specific regimens are:
- Nitrofurantoin monohydrate/macrocrystals (Macrobid): 100 mg twice daily for 5 days 1
- Nitrofurantoin macrocrystal: 50-100 mg four times daily for 5 days 1
- Nitrofurantoin macrocrystal prolonged release: 100 mg twice daily for 5 days 1
The FDA label states 100 mg every 12 hours for 7 days 2, but the most recent 2026 European guidelines support the shorter 5-day course 1, which is consistent with high-quality trial data showing 5-day nitrofurantoin is more effective than single-dose fosfomycin 3.
Key Administration Details
- Always take with food - this increases bioavailability by approximately 40% 2
- The twice-daily Macrobid formulation is preferred over four-times-daily dosing for better adherence
Treatment in Men
For men with uncomplicated UTI (no prostate involvement), nitrofurantoin can be used, though duration recommendations are less established 1. The FDA label suggests 7 days 2, and this longer duration is reasonable given limited evidence in males.
Prophylaxis Dosing
For recurrent UTI prophylaxis in adults, use 50 mg once daily at bedtime rather than 100 mg daily 4.
A 2022 cohort study of 1,893 patients demonstrated that 50 mg daily prophylaxis had:
- Equivalent effectiveness to 100 mg in preventing UTI recurrence (14.8% vs 14.9% infection rates) 4
- Significantly fewer adverse effects, with lower rates of cough (HR 1.82), dyspnea (HR 2.68), and nausea (HR 2.43) compared to 100 mg 4
The 2026 European guidelines do not specify prophylaxis dosing but acknowledge nitrofurantoin as an appropriate prophylactic agent 1.
Pediatric Dosing
For children over 12 years: 100 mg every 12 hours for 5-7 days 2, 5
The 2026 pediatric UTI guidelines recommend:
- Ages 2-5 years with nonfebrile UTI (cystitis): 3-5 days of antibiotics 5
- Ages 2 months to 24 months with febrile UTI: 5-7 days 5
- Ages >2 years with febrile UTI/pyelonephritis: 5-7 days 5
- High-risk children (ages 8 days-2 months, anatomic abnormalities, bacteremia, poor response): 7-14 days 5
While nitrofurantoin is mentioned as an option in pediatric studies 6, the FDA label only provides dosing for children over 12 years 2. For younger children, nitrofurantoin dosing should be calculated based on weight (typically 5-7 mg/kg/day divided into 4 doses for macrocrystalline formulations).
Important Pediatric Considerations
- Nitrofurantoin prophylaxis in children with neurogenic bladder showed effectiveness at once-daily dosing 6
- The drug is generally not recommended for infants under 1 month due to risk of hemolytic anemia
Critical Caveats
Do not use nitrofurantoin for suspected pyelonephritis - it achieves low serum and tissue concentrations and is only effective for bladder infections 2, 1.
Contraindications include:
- Creatinine clearance <30 mL/min (inadequate urinary concentrations)
- Pregnancy at term (risk of hemolytic anemia in newborn)
- Infants under 1 month of age
Common pitfall: The brown discoloration of urine is expected and harmless 2. Warn patients to avoid unnecessary concern or discontinuation.
Resistance considerations: Nitrofurantoin maintains excellent activity against E. coli and other common uropathogens with minimal resistance development, making it ideal for first-line use 2, 7. It has no activity against Proteus, Serratia, or Pseudomonas species 2.